SAM
PCRX icon

Sawgrass Asset Management’s Pacira BioSciences PCRX Stock Holding History

Sawgrass Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,774
Closed -$229K – 178
2021
Q2 		$229K Sell
3,774
-2,430
-39% -$154K 0.02% 156
2021
Q1 		$435K Sell
6,204
-1,205
-16% -$86.1K 0.04% 118
2020
Q4 		$443K Sell
7,409
-1,693
-19% -$99.1K 0.03% 113
2020
Q3 		$547K Buy
9,102
+825
+10% +$47.9K 0.04% 100
2020
Q2 		$434K Buy
+8,277
New +$346K 0.03% 104

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Sawgrass Asset Management's PCRX Position: Q3 2021 in Review

Sawgrass Asset Management sold out of Pacira BioSciences (PCRX) in Q3 2021, closing a stake of 3,774 shares — an estimated $229K sold.

Sawgrass Asset Management first reported a position in PCRX in Q2 2020 and held it in 5 quarters. The position peaked at $547K in Q3 2020. 259 funds tracked by Wall St. Rank hold PCRX as of Q3 2021.

  • Sawgrass Asset Management reported no remaining Pacira BioSciences position as of Q3 2021 after selling out during the quarter.
  • Sawgrass Asset Management sold 3,774 Pacira BioSciences shares in Q3 2021, an estimated $229K.
  • Sawgrass Asset Management first reported a position in Pacira BioSciences in Q2 2020 and held it in 5 quarters.
  • Sawgrass Asset Management's Pacira BioSciences position peaked at $547K in Q3 2020.
  • 259 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2021.

Based on Sawgrass Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.